STOCK TITAN

Vanguard reports zero stake in Cognex (NASDAQ: CGNX) after realignment

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group files an amendment stating it holds 0 shares (0%) of Cognex Corp common stock. The filing notes an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries to report holdings separately. The statement is signed by Ashley Grim, Head of Global Fund Administration on 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial ownership after internal reorganization.

The filing shows 0 shares (0%) beneficially owned of Cognex common stock and explains a January 12, 2026 internal realignment that led to disaggregated reporting by Vanguard subsidiaries. This is an administrative disclosure reflecting reporting structure rather than trading activity.

Cash‑flow treatment and any subsidiary holdings are not detailed in the excerpt; subsequent filings from the named subsidiaries may show beneficial positions if applicable.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

Does The Vanguard Group currently own any Cognex (CGNX) shares?

No. The filing states The Vanguard Group beneficially owns 0 shares (0%) of Cognex common stock as reported in this amendment, with no sole or shared voting or dispositive power disclosed.

Why does Vanguard say subsidiaries will report separately for CGNX?

Vanguard cites an internal realignment on January 12, 2026, and references SEC Release No. 34-39538, saying certain subsidiaries now report beneficial ownership on a disaggregated basis rather than under The Vanguard Group umbrella.

Who signed the Schedule 13G/A for Vanguard regarding Cognex?

The amendment is signed by Ashley Grim, identified as Head of Global Fund Administration, with the signature dated 03/26/2026, attesting to the reported ownership information.

Does this filing indicate any purchases or sales of CGNX by Vanguard?

No. The amendment reports an ownership position of 0 shares (0%) and explains reporting changes due to organizational realignment; it does not disclose purchases, sales, or cash‑flow details in the provided excerpt.

Will this Schedule 13G/A affect Cognex shareholder voting outcomes?

Unlikely based on this filing: The Vanguard Group reports 0 voting power in the excerpt. Any voting impact would depend on holdings reported separately by Vanguard subsidiaries, not disclosed here.
Cognex Corp

NASDAQ:CGNX

View CGNX Stock Overview

CGNX Rankings

CGNX Latest News

CGNX Latest SEC Filings

CGNX Stock Data

8.62B
166.42M
Scientific & Technical Instruments
Industrial Instruments for Measurement, Display, and Control
Link
United States
NATICK